WILLIAMS, S. Revising the Guidance Document for Biosimilar Agents. Health Reform Observer – Observatoire des Réformes de Santé, [S. l.], v. 5, n. 1, 2017. DOI: 10.13162/hro-ors.v5i1.2982. Disponível em: https://mulpress.mcmaster.ca/hro-ors/article/view/2982. Acesso em: 14 mar. 2025.